$240 Million is the total value of Nextech Invest Ltd.'s 12 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 14.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RVMD | Buy | REVOLUTION MEDICINES INC | $104,824,198 | +5.0% | 4,839,529 | +15.5% | 43.76% | +10.2% |
| TYRA BIOSCIENCES INC | $40,473,613 | +111.4% | 2,518,582 | 0.0% | 16.89% | +121.9% | ||
| EQRX INC | $25,422,583 | -21.1% | 13,104,424 | 0.0% | 10.61% | -17.3% | ||
| KNTE | KINNATE BIOPHARMA INC | $14,559,250 | +2.5% | 2,329,480 | 0.0% | 6.08% | +7.5% | |
| CGEM | CULLINAN ONCOLOGY INC | $12,492,313 | -3.0% | 1,221,145 | 0.0% | 5.21% | +1.7% | |
| SBTX | ARS PHARMACEUTICALS INC | $12,434,289 | -23.7% | 1,910,029 | 0.0% | 5.19% | -19.9% | |
| RLAY | Buy | RELAY THERAPEUTICS INC | $10,301,738 | +45.0% | 625,485 | +31.5% | 4.30% | +52.2% |
| ARVN | ARVINAS INC | $7,847,697 | -20.1% | 287,251 | 0.0% | 3.28% | -16.2% | |
| THESEUS PHARMACEUTICALS INC | $5,428,433 | +78.3% | 611,310 | 0.0% | 2.27% | +87.1% | ||
| PMVP | Sell | PMV PHARMACEUTICALS INC | $2,486,525 | -79.4% | 521,284 | -62.4% | 1.04% | -78.4% |
| KRON | KRONOS BIO INC | $2,119,244 | -9.9% | 1,451,537 | 0.0% | 0.88% | -5.3% | |
| CCCC | C4 THERAPEUTICS INC | $1,180,191 | -46.8% | 375,857 | 0.0% | 0.49% | -44.1% | |
| BPMC | Exit | BLUEPRINT MEDICINES CORP | $0 | – | -188,228 | -100.0% | -3.28% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -263,914 | -100.0% | -4.76% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| REVOLUTION MEDICINES INC | 8 | Q3 2023 | 44.0% |
| EQRX INC | 8 | Q3 2023 | 23.5% |
| TYRA BIOSCIENCES INC | 8 | Q3 2023 | 16.9% |
| KINNATE BIOPHARMA INC | 8 | Q3 2023 | 14.0% |
| CULLINAN ONCOLOGY INC | 8 | Q3 2023 | 5.3% |
| PMV PHARMACEUTICALS INC | 8 | Q3 2023 | 8.4% |
| ARVINAS INC | 8 | Q3 2023 | 6.2% |
| SILVERBACK THERAPEUTICS INC | 8 | Q3 2023 | 6.5% |
| KRONOS BIO INC | 8 | Q3 2023 | 5.2% |
| THESEUS PHARMACEUTICALS INC | 8 | Q3 2023 | 2.3% |
View Nextech Invest Ltd.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-01 |
| 13F-HR/A | 2022-05-16 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
View Nextech Invest Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.